Gepefrine: Difference between revisions

	WikiDoc Resources for Gepefrine
Articles
Most recent articles on Gepefrine Most cited articles on Gepefrine Review articles on Gepefrine Articles on Gepefrine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Gepefrine Images of Gepefrine Photos of Gepefrine Podcasts & MP3s on Gepefrine Videos on Gepefrine
Evidence Based Medicine
Cochrane Collaboration on Gepefrine Bandolier on Gepefrine TRIP on Gepefrine
Clinical Trials
Ongoing Trials on Gepefrine at Clinical Trials.gov Trial results on Gepefrine Clinical Trials on Gepefrine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Gepefrine NICE Guidance on Gepefrine NHS PRODIGY Guidance FDA on Gepefrine CDC on Gepefrine
Books
Books on Gepefrine
News
Gepefrine in the news Be alerted to news on Gepefrine News trends on Gepefrine
Commentary
Blogs on Gepefrine
Definitions
Definitions of Gepefrine
Patient Resources / Community
Patient resources on Gepefrine Discussion groups on Gepefrine Patient Handouts on Gepefrine Directions to Hospitals Treating Gepefrine Risk calculators and risk factors for Gepefrine
Healthcare Provider Resources
Symptoms of Gepefrine Causes & Risk Factors for Gepefrine Diagnostic studies for Gepefrine Treatment of Gepefrine
Continuing Medical Education (CME)
CME Programs on Gepefrine
International
Gepefrine en Espanol Gepefrine en Francais
Business
Gepefrine in the Marketplace Patents on Gepefrine
Experimental / Informatics
List of terms related to Gepefrine

Gepefrine
Clinical data
ATC code	C01CA15 (WHO) ;
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name (±)-3-(2-aminopropyl)phenol;
CAS Number	1075-61-2 ; 18840-47-6 ((S)-form); 60763-48-6 (tartrate);
PubChem CID	219105;
ChemSpider	189921 ;
UNII	V51RRX51VH;
KEGG	D07150 ;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C9H13NO
Molar mass	151.206 g/mol
3D model (JSmol)	Interactive image;
	SMILES OC1=CC(C[C@H](C)N)=CC=C1;
	InChI InChI=1S/C9H13NO/c1-7(10)5-8-3-2-4-9(11)6-8/h2-4,6-7,11H,5,10H2,1H3/t7-/m0/s1 ; Key:WTDGMHYYGNJEKQ-ZETCQYMHSA-N ;
(verify)

VisualWikitext

Revision as of 15:11, 13 April 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Gepefrine (INN; trade names Pressionorm and Wintonin), also known as 3-hydroxyamphetamine, meta-hydroxyamphetamine,^[1] and α-methyl-meta-tyramine, is an antihypotensive or sympathomimetic agent of the amphetamine family that is marketed in certain European countries.^[2]^[3]

It is a known metabolite of amphetamine in rats.^[1]

References

↑ ^1.0 ^1.1 Jonsson J (October 1977). "Identification of metahydroxyamphetamine as a metabolite of amphetamine in the rat". Research Communications in Chemical Pathology and Pharmacology. 18 (2): 189–99. PMID 918344.
↑ Index Nominum 2000: International Drug Directory. Taylor & Francis US. 2000. p. 487. ISBN 978-3-88763-075-1. Retrieved 24 April 2012.
↑ F.. Macdonald (1997). Dictionary of Pharmacological Agents. CRC Press. p. 127. ISBN 978-0-412-46630-4. Retrieved 24 April 2012.

Template:Catecholaminergics Template:Phenethylamines

[pmid918344-1] 1.0 ^1.1 Jonsson J (October 1977). "Identification of metahydroxyamphetamine as a metabolite of amphetamine in the rat". Research Communications in Chemical Pathology and Pharmacology. 18 (2): 189–99. PMID 918344.

[Index_Nominum_2000:_International_Drug_Directory-2] Index Nominum 2000: International Drug Directory. Taylor & Francis US. 2000. p. 487. ISBN 978-3-88763-075-1. Retrieved 24 April 2012.

[Macdonald1997-3] F.. Macdonald (1997). Dictionary of Pharmacological Agents. CRC Press. p. 127. ISBN 978-0-412-46630-4. Retrieved 24 April 2012.

[1]

[2]

[3]

@@ Line 1: / Line 1: @@
 {{Drugbox
-| IUPAC_name        = 3-(2-aminopropyl)phenol
+| Watchedfields = changed
-| image             = gepefrine.png
+| verifiedrevid = 447926897
-| CAS_number        =
+| IUPAC_name = (±)-3-(2-aminopropyl)phenol
-| ATC_prefix        = C01
+| image =Gepefrine.png
-| ATC_suffix        = CA15
+| imagename = Gepefrine
-| PubChem           = 102551
-| DrugBank          =
+<!--Clinical data-->
-| C=9|H=13|N=1|O=1
+| tradename =
-| molecular_weight  = 151.206 g/mol
+| pregnancy_category =
-| bioavailability   =
+| legal_status = Rx-only
-| protein_bound     =
+| routes_of_administration =
-| metabolism        =
-| elimination_half-life =
+<!--Pharmacokinetic data-->
-| excretion         =
+| bioavailability =
-| pregnancy_AU      =  <!-- A / B1 / B2 / B3 / C / D / X -->
+| metabolism =
-| pregnancy_US      =  <!-- A / B            / C / D / X -->
+| elimination_half-life =
-| pregnancy_category=
+| excretion =
-| legal_AU          =  <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
-| legal_CA          =  <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
+<!--Identifiers-->
-| legal_UK          =  <!-- GSL         / P       / POM / CD / Class A, B, C -->
+| CAS_number_Ref = {{cascite|correct|??}}
-| legal_US          =  <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
+| CAS_number = 1075-61-2
-| legal_status      =
+| CAS_supplemental = <br />18840-47-6 ((''S'')-form)<br />60763-48-6 ([[tartrate]])
-| routes_of_administration =
+| ATC_prefix = C01
+| ATC_suffix = CA15
+| PubChem = 219105
+| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
+| ChemSpiderID = 189921
+| UNII_Ref = {{fdacite|correct|FDA}}
+| UNII = V51RRX51VH
+| KEGG_Ref = {{keggcite|correct|kegg}}
+| KEGG = D07150
+<!--Chemical data-->
+| C = 9 | H = 13 | N = 1 | O = 1
+| molecular_weight = 151.206 g/mol
+| smiles = OC1=CC(C[C@H](C)N)=CC=C1
+| InChI = 1/C9H13NO/c1-7(10)5-8-3-2-4-9(11)6-8/h2-4,6-7,11H,5,10H2,1H3/t7-/m0/s1
+| InChIKey = WTDGMHYYGNJEKQ-ZETCQYMHBW
+| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
+| StdInChI = 1S/C9H13NO/c1-7(10)5-8-3-2-4-9(11)6-8/h2-4,6-7,11H,5,10H2,1H3/t7-/m0/s1
+| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
+| StdInChIKey = WTDGMHYYGNJEKQ-ZETCQYMHSA-N
 }}
-__NOTOC__
+__Notoc__
+{{SI}}
 {{CMG}}
+==Overview==
+'''Gepefrine''' ([[International Nonproprietary Name|INN]]; trade names '''Pressionorm''' and '''Wintonin'''), also known as '''3-hydroxyamphetamine''', '''''meta''-hydroxyamphetamine''',<ref name="pmid918344">{{cite journal | author = Jonsson J | title = Identification of metahydroxyamphetamine as a metabolite of amphetamine in the rat | journal = Research Communications in Chemical Pathology and Pharmacology | volume = 18 | issue = 2 | pages = 189–99 |date=October 1977 | pmid = 918344 | doi = | url = }}</ref> and '''α-methyl-''meta''-tyramine''', is an [[antihypotensive]] or [[sympathomimetic]] agent of the [[amphetamine]] family that is marketed in certain [[Europe]]an countries.<ref name="Index Nominum 2000: International Drug Directory">{{cite book | title = Index Nominum 2000: International Drug Directory | url = http://books.google.com/books?id=5GpcTQD_L2oC&pg=PA487 | accessdate = 24 April 2012 | year = 2000 | publisher = Taylor & Francis US | isbn = 978-3-88763-075-1 | page = 487}}</ref><ref name="Macdonald1997">{{cite book | author = F.. Macdonald | title = Dictionary of Pharmacological Agents | url = http://books.google.com/books?id=DeX7jgInYFMC&pg=PA127 | accessdate = 24 April 2012 | year = 1997 | publisher = CRC Press | isbn = 978-0-412-46630-4 | page = 127}}</ref>
+It is a known [[metabolite]] of [[amphetamine]] in rats.<ref name="pmid918344" />
+== See also ==
+* [[3,4-Dihydroxyamphetamine]]
+* [[Norfenfluramine]]
+* [[4-Hydroxyamphetamine]]
+* [[Metaraminol]]
+* [[meta-Tyramine|''meta''-Tyramine]]
-==[[Gepefrine (patient information)|For patient information, click here]]==
+== References ==
+{{Reflist|2}}
-==Overview==
-'''Gepefrine''' is a cardiac stimulant.
-{{Cardiac stimulants excluding cardiac glycosides}}
+{{Catecholaminergics}}
+{{Phenethylamines}}
+[[Category:Substituted amphetamines]]
 [[Category:Phenols]]
-[[Category:Phenethylamines]]
+[[Category:Sympathomimetics]]
-[[Category:Drugs]]
+[[Category:Norepinephrine-dopamine releasing agents]]
-{{WikiDoc Help Menu}}
+[[Category:Drug]]
-{{WikiDoc Sources}}

Clinical data

ATC code	C01CA15 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name (±)-3-(2-aminopropyl)phenol
CAS Number	1075-61-2^Y 18840-47-6 ((S)-form) 60763-48-6 (tartrate)
PubChem CID	219105
ChemSpider	189921^Y
UNII	V51RRX51VH
KEGG	D07150^Y
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₉H₁₃NO
Molar mass	151.206 g/mol
3D model (JSmol)	Interactive image
SMILES OC1=CC(C[C@H](C)N)=CC=C1
InChI InChI=1S/C9H13NO/c1-7(10)5-8-3-2-4-9(11)6-8/h2-4,6-7,11H,5,10H2,1H3/t7-/m0/s1^Y Key:WTDGMHYYGNJEKQ-ZETCQYMHSA-N^Y
(verify)

Gepefrine: Difference between revisions

Revision as of 15:11, 13 April 2015

Overview

See also

References

Navigation menu